AnalystsTrevor AllredTrevor Allred's Stock Forecasts
AnalystsTrevor Allred
Sectors:
Industries:
Analyst Ranking
Top 28%
#1439 out of 5116 analysts
Average Return
+65.52%
Win Rate
100%8 out of 8
Risk vs Reward
Poor
Good
Trevor Allred's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mbx Biosciences IncMBX | +177.47% | $12.43 | $34.49 | 2025-07-16 - 2025-11-28 | Buy |
Ligand Pharmaceuticals IncLGND | +94.47% | $104.48 | $203.18 | 2025-05-09 - 2025-11-28 | Buy |
Mbx Biosciences IncMBX | +81.91% | $18.96 | $34.49 | 2025-09-23 - 2025-11-28 | Buy |
Palvella Therapeutics IncPVLA | +81.26% | $56.71 | $102.79 | 2025-09-09 - 2025-11-28 | Buy |
Ligand Pharmaceuticals IncLGND | +50.25% | $135.23 | $203.18 | 2025-07-30 - 2025-11-28 | Buy |
Trevor Allred Analyst Color
Get additional color on Trevor Allred's coverage of popular stocks
Trevor Allred's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ligand Pharmaceuticals IncLGND | 4 | Buy | $250.00 | +23.04% | Maintains | a month ago |
Mbx Biosciences IncMBX | 2 | Buy | $80.00 | +131.95% | Maintains | 2 months ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $85.00 | -17.31% | Initiates Coverage On | 3 months ago |
Innoviva IncINVA | 1 | Buy | $35.00 | +61.07% | Initiates Coverage On | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.